Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Human Umbilical Cord Mesenchymal Stem Cell Bank is a specialized biotechnology facility located in Qingdao, China, focused on the collection, processing, and long-term cryopreservation of mesenchymal stem cells (MSCs) derived from umbilical cord tissue. Established to support the growing field of regenerative medicine, the bank provides high-quality biological resources for both private family storage and clinical research applications. It operates under the management of Vcanbio (Zhongyuan Union), one of China's leading cell and gene engineering companies. The facility adheres to rigorous quality control standards to ensure the safety, purity, and viability of the stored stem cells. By collaborating with local hospitals and research institutions, the bank facilitates the development of cell-based therapies for conditions such as autoimmune diseases, neurological disorders, and tissue injuries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Human Umbilical Cord Mesenchymal Stem Cell Bank.